Dataset Information

Comparing nominal and real quality scores on next-generation sequencing genotype calls.

ABSTRACT: I seek to comprehensively evaluate the quality of the Genetic Analysis Workshop 17 (GAW17) data set by examining the accuracy of its genotype calls, which were based on the pilot3 data of the 1000 Genomes Project. Taking advantage of the 1000 Genomes Project/HapMap sample intersect, I compared GAW17 genotype calls to HapMap III, release 2, genotype calls for an individual. These genotype calls should be concordant almost everywhere. Instead I found an astonishingly low 65.4% concordance. Regarding HapMap as the gold standard, I assume that this is a GAW17 data problem and seek to explain this discordance accordingly. I found that a large proportion of this discordance occurred outside targeted regions and that concordance could be improved to at least 94.6% by simply staying within targeted regions, which were sequenced across more samples. Furthermore, I found that in certain individuals, high sample counts did little to improve concordance and concluded that quality scores for a certain sample's sequence reads were simply incorrect.

SUBMITTER: Stram AH

PROVIDER: S-EPMC3287848 | biostudies-literature | 2011 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Comparing nominal and real quality scores on next-generation sequencing genotype calls.

Stram Alexander H AH

BMC proceedings 20111129

I seek to comprehensively evaluate the quality of the Genetic Analysis Workshop 17 (GAW17) data set by examining the accuracy of its genotype calls, which were based on the pilot3 data of the 1000 Genomes Project. Taking advantage of the 1000 Genomes Project/HapMap sample intersect, I compared GAW17 genotype calls to HapMap III, release 2, genotype calls for an individual. These genotype calls should be concordant almost everywhere. Instead I found an astonishingly low 65.4% concordance. Regardi ...[more]

PMID: 22373481

Similar Datasets

Project description:Molecular technologies have allowed laboratories to detect and establish the profiles of human cancers by identifying a variety of somatic variants. In order to improve personalized patient care, we have established a next-generation sequencing (NGS) test to screen for somatic variants in primary or advanced cancers. In this study, we describe the laboratory quality management program for NGS testing, and also provide an overview of the somatic variants identified in over 1000 patient samples as well as their implications in clinical practice.Over the past one-and-a-half years, our laboratory received a total of 1028 formalin-fixed, paraffin-embedded (FFPE) tumor tissues, which consisted of non-small-cell lung carcinomas (NSCLCs), colon adenocarcinomas, glioma/glioblastomas, melanomas, breast carcinomas, and other tumor types. During this time period, we implemented a series of quality control (QC) checks that included (1) pre-DNA extraction, (2) DNA quantification, (3) DNA quality, (4) library quantification, (5) post-emulsification PCR, and (6) post-sequencing metrics. At least 10 ng of genomic DNA (gDNA) were used to prepare barcoded libraries using the AmpliSeq CHPv2. Samples were multiplexed and sequenced on Ion Torrent 318 chips using the Ion PGM System. Variants were identified using the Variant Caller Plugin, and annotation and functional predictions were performed using the Golden Helix SVS.A total of 1005 samples passed QC1-3, and following additional library preparation QC checkpoints, 877 samples were sequenced. Samples were classified into two categories: wild-type (127) and positive for somatic variants (750). Somatic variants were classified into clinically actionable (60%) and non-actionable (40%).The use of NGS in routine clinical laboratory practice allowed for the detection of tumor profiles that are essential for the selection of targeted therapies and identification of applicable clinical trials, contributing to the improvement of personalized patient care in oncology.

Dataset Information

Comparing nominal and real quality scores on next-generation sequencing genotype calls.

Publications

Comparing nominal and real quality scores on next-generation sequencing genotype calls.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets